Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: Randomised clinical trial

We evaluated the safety and efficacy of closed-loop with meal announcement (CLMA) during reduction and omission of meal insulin boluses in adolescents with type 1 diabetes (T1D). Twelve adolescents with T1D [M 6; age 15.9 (1.8) yrs; HbA1c 77 (27) mmol/mol] were studied in a randomised crossover stud...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elleri, Daniela, Maltoni, Giulio, Allen, Janet M, Nodale, Marianna, Kumareswaran, Kavita, Leelarathna, Lalantha, Thabit, Hood, Caldwell, Karen, Wilinska, Malgorzata E, Calhoun, Peter, Kollman, Craig, Dunger, David B, Hovorka, Roman
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4192111/
https://ncbi.nlm.nih.gov/pubmed/24909206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12324
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires